Anupam Rao1, Sheridan O'Donnell2, Nicole Bain3, Cliff Meldrum3, Damon Shorter4, Himanshu Goel5. 1. University of Newcastle, Newcastle - School of Medicine and Public Health, Faculty of Health, Level 1, Bowman Building, Callaghan, NSW 2308, Australia; Hunter Genetics, Newcastle, PO Box 84, Waratah, NSW 2298, Australia. 2. Hunter Genetics, Newcastle, PO Box 84, Waratah, NSW 2298, Australia. 3. Department of Molecular Medicine, Hunter Area Pathology Service, Newcastle, John Hunter Hospital, Lookout Rd, Rankin Park, 2305 NSW, Australia. 4. 14 Lindsey St, Gosford, NSW 2250, Australia. 5. Hunter Genetics, Newcastle, PO Box 84, Waratah, NSW 2298, Australia; University of Newcastle, Newcastle - School of Medicine and Public Health, Faculty of Health, Level 1, Bowman Building, Callaghan, NSW 2308, Australia. Electronic address: himanshu.goel@hnehealth.nsw.gov.au.
Abstract
BACKGROUND: Chromosome 1p31 deletion (OMIM #613735) involving the NFIA gene (OMIM 600727) is characterised by variable defects in the formation of the corpus callosum, craniofacial abnormalities and urinary tract defects. A review of current literature suggests only seven cases have been reported, none of which had an isolated NFIA gene defect. METHODS: We submit the clinical and molecular features of an 8-year-old female patient with a microdeletion of chromosome 1p31.3 who has developmental delay, metopic synostosis and macroscopic haemoglobinuria. She was investigated with karyotyping, subtelomeric FISH and microarray CGH. RESULTS: Array CGH identified a single 120 kb microdeletion of 1p31.3 involving exons 4-9 of the NFIA gene. Her brain MRI showed hypoplasia of the corpus callosum especially in the posterior areas. Karyotype was normal, ruling out structural chromosomal abnormalities. CONCLUSION: In this study, we confirmed that a microdeletion in the chromosome region 1p31.3 involving the NFIA gene is associated with hypoplasia of the corpus callosum, developmental delay, metopic synostosis and urinary tract abnormalities. Furthermore, we propose a mechanism by which disruptions in the NFIA gene causes craniofacial abnormalities. This report presents the first case of an intragenic deletion within the NFIA gene that is still consistent with classic clinical phenotypes present in previously reported cases of chromosome 1p31.3 related deletion. This finding will help clarify the role of the NFIA gene in the normal formation of parts of the CNS, the craniofacial complex and the urinary tract. Crown
BACKGROUND: Chromosome 1p31 deletion (OMIM #613735) involving the NFIA gene (OMIM 600727) is characterised by variable defects in the formation of the corpus callosum, craniofacial abnormalities and urinary tract defects. A review of current literature suggests only seven cases have been reported, none of which had an isolated NFIA gene defect. METHODS: We submit the clinical and molecular features of an 8-year-old female patient with a microdeletion of chromosome 1p31.3 who has developmental delay, metopic synostosis and macroscopic haemoglobinuria. She was investigated with karyotyping, subtelomeric FISH and microarray CGH. RESULTS: Array CGH identified a single 120 kb microdeletion of 1p31.3 involving exons 4-9 of the NFIA gene. Her brain MRI showed hypoplasia of the corpus callosum especially in the posterior areas. Karyotype was normal, ruling out structural chromosomal abnormalities. CONCLUSION: In this study, we confirmed that a microdeletion in the chromosome region 1p31.3 involving the NFIA gene is associated with hypoplasia of the corpus callosum, developmental delay, metopic synostosis and urinary tract abnormalities. Furthermore, we propose a mechanism by which disruptions in the NFIA gene causes craniofacial abnormalities. This report presents the first case of an intragenic deletion within the NFIA gene that is still consistent with classic clinical phenotypes present in previously reported cases of chromosome 1p31.3 related deletion. This finding will help clarify the role of the NFIA gene in the normal formation of parts of the CNS, the craniofacial complex and the urinary tract. Crown
Authors: Ilan Gobius; Laura Morcom; Rodrigo Suárez; Jens Bunt; Polina Bukshpun; William Reardon; William B Dobyns; John L R Rubenstein; A James Barkovich; Elliott H Sherr; Linda J Richards Journal: Cell Rep Date: 2016-10-11 Impact factor: 9.423
Authors: Carlos I Rivera-Pedroza; Jimena Barraza-García; Beatriz Paumard-Hernández; Julian Nevado; Carlos Orbea-Gallardo; Jaime Sánchez Del Pozo; Karen E Heath Journal: Mol Syndromol Date: 2016-11-17
Authors: Ina Schanze; Jens Bunt; Jonathan W C Lim; Denny Schanze; Ryan J Dean; Marielle Alders; Patricia Blanchet; Tania Attié-Bitach; Siren Berland; Steven Boogert; Sangamitra Boppudi; Caitlin J Bridges; Megan T Cho; William B Dobyns; Dian Donnai; Jessica Douglas; Dawn L Earl; Timothy J Edwards; Laurence Faivre; Brieana Fregeau; David Genevieve; Marion Gérard; Vincent Gatinois; Muriel Holder-Espinasse; Samuel F Huth; Kosuke Izumi; Bronwyn Kerr; Elodie Lacaze; Phillis Lakeman; Sonal Mahida; Ghayda M Mirzaa; Sian M Morgan; Catherine Nowak; Hilde Peeters; Florence Petit; Daniela T Pilz; Jacques Puechberty; Eyal Reinstein; Jean-Baptiste Rivière; Avni B Santani; Anouck Schneider; Elliott H Sherr; Constance Smith-Hicks; Ilse Wieland; Elaine Zackai; Xiaonan Zhao; Richard M Gronostajski; Martin Zenker; Linda J Richards Journal: Am J Hum Genet Date: 2018-11-01 Impact factor: 11.025
Authors: Jonathan D J Labonne; Yiping Shen; Il-Keun Kong; Michael P Diamond; Lawrence C Layman; Hyung-Goo Kim Journal: Mol Cytogenet Date: 2016-03-17 Impact factor: 2.009